ORBIMED ADVISORS LLC Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$8.3T
Holdings
147
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (147 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | PIRSPIERIS PHARMACEUTICALS INC | 2,455,900 | $13.8B | 0.17% | |
| 102 | —RADIUS HEALTH INC | 762,900 | $13.6B | 0.16% | |
| 103 | —AVROBIO INC | 250,000 | $13.0B | 0.16% | |
| 104 | —NABRIVA THERAPEUTICS PLC | 4,644,600 | $12.5B | 0.15% | |
| 105 | —WRIGHT MED GROUP N V | 8,746,583 | $12.2B | 0.15% | |
| 106 | —NOVUS THERAPEUTICS INC | 2,537,110 | $11.8B | 0.14% | |
| 107 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 309,500 | $11.8B | 0.14% | |
| 108 | ACIUAC IMMUNE SA | 1,440,000 | $11.5B | 0.14% | |
| 109 | —DERMIRA INC | 1,031,596 | $11.2B | 0.14% | |
| 110 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $10.8B | 0.13% | |
| 111 | HCAHCA HEALTHCARE INC | 75,900 | $10.6B | 0.13% | |
| 112 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 666,593 | $9.0B | 0.11% | |
| 113 | ALLKGUSDALLAKOS INC | 200,000 | $9.0B | 0.11% | |
| 114 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $8.6B | 0.10% | |
| 115 | XENEXENON PHARMACEUTICALS INC | 634,812 | $8.4B | 0.10% | |
| 116 | FLBFLUIDIGM CORP DEL | 1,077,801 | $8.1B | 0.10% | |
| 117 | —INOTEK PHARMACEUTICALS CORP | 7,000,000 | $7.8B | 0.09% | |
| 118 | —NUVECTRA CORP | 350,000 | $7.7B | 0.09% | |
| 119 | BMRNBIOMARIN PHARMACEUTICAL INC | 76,500 | $7.4B | 0.09% | |
| 120 | —111 INC | 500,000 | $6.8B | 0.08% | |
| 121 | ATNXEURATHENEX INC | 430,000 | $6.7B | 0.08% | |
| 122 | ALKSALKERMES PLC | 145,000 | $6.2B | 0.07% | |
| 123 | —MARINUS PHARMACEUTICALS INC | 567,600 | $5.7B | 0.07% | |
| 124 | —CONSTELLATION PHARMCETICLS I | 835,842 | $5.6B | 0.07% | |
| 125 | ECORGBPELECTROCORE INC | 397,826 | $5.6B | 0.07% | |
| 126 | —RA MED SYS INC | 300,000 | $5.5B | 0.07% | |
| 127 | STIMNEURONETICS INC | 150,000 | $4.8B | 0.06% | |
| 128 | —MENLO THERAPEUTICS INC | 472,729 | $4.7B | 0.06% | |
| 129 | CPRXCATALYST PHARMACEUTICALS INC | 1,102,000 | $4.2B | 0.05% | |
| 130 | —GW PHARMACEUTICALS PLC | 21,000 | $3.6B | 0.04% | |
| 131 | SNDXSYNDAX PHARMACEUTICALS INC | 437,000 | $3.5B | 0.04% | |
| 132 | MGTXMEIRAGTX HOLDINGS PLC | 253,183 | $3.4B | 0.04% | |
| 133 | —REALM THERAPEUTICS PLC | 1,021,484 | $3.1B | 0.04% | |
| 134 | —ARSANIS INC | 1,868,966 | $3.0B | 0.04% | |
| 135 | —TESARO INC | 67,281 | $2.6B | 0.03% | |
| 136 | RDHLGBPREDHILL BIOPHARMA LTD | 284,900 | $2.5B | 0.03% | |
| 137 | —ADAMAS PHARMACEUTICALS INC | 100,000 | $2.0B | 0.02% | |
| 138 | ANABANAPTYSBIO INC | 20,000 | $2.0B | 0.02% | Put |
| 139 | —AEGERION PHARMACEUTICALS INC | 2,000,000 | $1.6B | 0.02% | |
| 140 | —AFFIMED N V | 326,650 | $1.4B | 0.02% | |
| 141 | —SIERRA ONCOLOGY INC | 767,104 | $1.3B | 0.02% | |
| 142 | —BIOLINERX LTD | 1,038,600 | $1.1B | 0.01% | |
| 143 | SCTLRECRO PHARMA INC | 107,357 | $763.0M | 0.01% | |
| 144 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $602.0M | 0.01% | |
| 145 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $517.0M | 0.01% | |
| 146 | —ALIMERA SCIENCES INC | 250,000 | $245.0M | 0.00% | |
| 147 | —MEDIGUS LTD | 15,000 | $51.0M | 0.00% |
PreviousPage 2 of 2